⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for metastatic lung small cell carcinoma

Every month we try and update this database with for metastatic lung small cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking AbilityNCT04804644
Metastatic Lung...
Metastatic Mali...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Memantine Hydro...
Neurocognitive ...
Stereotactic Ra...
Whole-Brain Rad...
18 Years - NRG Oncology
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVNCT04514484
Advanced Differ...
Advanced Head a...
Advanced Hepato...
Advanced Kaposi...
Advanced Lung N...
Advanced Lung S...
Advanced Malign...
Advanced Melano...
Advanced Ovaria...
Advanced Prosta...
Advanced Renal ...
Advanced Thyroi...
Advanced Triple...
Advanced Urothe...
Anatomic Stage ...
Anatomic Stage ...
Castration-Resi...
Clinical Stage ...
Clinical Stage ...
HIV Infection
Metastatic Diff...
Metastatic Head...
Metastatic Hepa...
Metastatic Kapo...
Metastatic Lung...
Metastatic Lung...
Metastatic Mali...
Metastatic Mela...
Metastatic Ovar...
Metastatic Pros...
Metastatic Rena...
Metastatic Thyr...
Metastatic Trip...
Metastatic Urot...
Recurrent Diffe...
Recurrent Head ...
Recurrent Hepat...
Recurrent Kapos...
Recurrent Lung ...
Recurrent Lung ...
Recurrent Malig...
Recurrent Melan...
Recurrent Ovari...
Recurrent Prost...
Recurrent Renal...
Recurrent Thyro...
Recurrent Tripl...
Recurrent Uroth...
Refractory Diff...
Stage III Diffe...
Stage III Hepat...
Stage III Lung ...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Thyro...
Stage IV Differ...
Stage IV Hepato...
Stage IV Lung C...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Thyroi...
Biospecimen Col...
Cabozantinib S-...
Computed Tomogr...
Magnetic Resona...
Nivolumab
18 Years - National Cancer Institute (NCI)
Temozolomide and Atezolizumab as Second or Third Line for the Treatment of Metastatic or Recurrent Small Cell Lung CancerNCT04919382
Extensive Stage...
Metastatic Lung...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Atezolizumab
Temozolomide
18 Years - Big Ten Cancer Research Consortium
Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine TumorsNCT02589522
Metastatic Lung...
Metastatic Lung...
Metastatic Lung...
Metastatic Mali...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Berzosertib
Quality-of-Life...
Therapeutic Con...
Whole-Brain Rad...
18 Years - National Cancer Institute (NCI)
Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain MetastasisNCT04516070
Metastatic Lung...
Metastatic Mali...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Questionnaire A...
Stereotactic Ra...
18 Years - M.D. Anderson Cancer Center
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsNCT02498613
Advanced Malign...
Metastatic Lung...
Metastatic Lung...
Metastatic Panc...
Metastatic Trip...
Pancreatic Duct...
Stage III Breas...
Stage III Lung ...
Stage III Lung ...
Stage III Pancr...
Stage IIIA Brea...
Stage IIIA Lung...
Stage IIIA Lung...
Stage IIIB Brea...
Stage IIIB Lung...
Stage IIIB Lung...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Lung N...
Stage IV Lung S...
Stage IV Pancre...
Triple-Negative...
Unresectable Lu...
Unresectable Pa...
Unresectable Pa...
Unresectable Tr...
18F-Fluoromison...
Cediranib Malea...
Laboratory Biom...
Olaparib
Positron Emissi...
18 Years - National Cancer Institute (NCI)
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking AbilityNCT04804644
Metastatic Lung...
Metastatic Mali...
Recurrent Lung ...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Memantine Hydro...
Neurocognitive ...
Stereotactic Ra...
Whole-Brain Rad...
18 Years - NRG Oncology
A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid TumorsNCT02498613
Advanced Malign...
Metastatic Lung...
Metastatic Lung...
Metastatic Panc...
Metastatic Trip...
Pancreatic Duct...
Stage III Breas...
Stage III Lung ...
Stage III Lung ...
Stage III Pancr...
Stage IIIA Brea...
Stage IIIA Lung...
Stage IIIA Lung...
Stage IIIB Brea...
Stage IIIB Lung...
Stage IIIB Lung...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Lung N...
Stage IV Lung S...
Stage IV Pancre...
Triple-Negative...
Unresectable Lu...
Unresectable Pa...
Unresectable Pa...
Unresectable Tr...
18F-Fluoromison...
Cediranib Malea...
Laboratory Biom...
Olaparib
Positron Emissi...
18 Years - National Cancer Institute (NCI)
M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryNCT02595931
Metastatic Colo...
Metastatic Lung...
Metastatic Mali...
Metastatic Panc...
Refractory Colo...
Refractory Lung...
Refractory Mali...
Refractory Panc...
Stage III Color...
Stage III Lung ...
Stage III Pancr...
Stage IV Colore...
Stage IV Lung C...
Stage IV Pancre...
Unresectable Co...
Unresectable Lu...
Unresectable Ma...
Unresectable Pa...
Berzosertib
Biopsy Specimen
Biospecimen Col...
Computed Tomogr...
Irinotecan Hydr...
18 Years - National Cancer Institute (NCI)
Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine TumorsNCT02589522
Metastatic Lung...
Metastatic Lung...
Metastatic Lung...
Metastatic Mali...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Berzosertib
Quality-of-Life...
Therapeutic Con...
Whole-Brain Rad...
18 Years - National Cancer Institute (NCI)
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to Usual Chemotherapy for Advanced Stage Solid Tumors, With a Specific Focus on Patients With Small Cell Lung Cancer, Poorly Differentiated Neuroendocrine Cancer, and Pancreatic CancerNCT04514497
Metastatic Lung...
Metastatic Mali...
Metastatic Neur...
Metastatic Panc...
Stage III Lung ...
Stage III Pancr...
Stage IV Lung C...
Stage IV Pancre...
Unresectable Lu...
Unresectable Ma...
Unresectable Ne...
Unresectable Pa...
Biopsy
Biospecimen Col...
Computed Tomogr...
Elimusertib
Irinotecan Hydr...
Magnetic Resona...
Topotecan Hydro...
18 Years - National Cancer Institute (NCI)
Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain MetastasisNCT04516070
Metastatic Lung...
Metastatic Mali...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Questionnaire A...
Stereotactic Ra...
18 Years - M.D. Anderson Cancer Center
Testing the Safety of M6620 (VX-970) When Given With Standard Whole Brain Radiation Therapy for the Treatment of Brain Metastases From Non-small Cell Lung Cancer, Small Cell Lung Cancer, or Neuroendocrine TumorsNCT02589522
Metastatic Lung...
Metastatic Lung...
Metastatic Lung...
Metastatic Mali...
Stage IV Lung C...
Stage IVA Lung ...
Stage IVB Lung ...
Berzosertib
Quality-of-Life...
Therapeutic Con...
Whole-Brain Rad...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: